Home/Traverse Biotech/Hatem Azim, MD/PhD

HA

Hatem Azim, MD/PhD

Chief Medical Officer

Traverse Biotech

Therapeutic Areas

Traverse Biotech Pipeline

Drug	Indication	Phase
CD3 X ROR2 DuoBody	Multiple Oncology Indications	Preclinical
Targeting Innate Immunity	Oncology and Aging	Research

Leadership Team at Traverse Biotech

Brandy Houser, PhD

Co-Founder & CEO

William Polvino, MD

Co-Founder & Chairman

Jean-Loup Romet-Lemonne, MD

Co-Founder & President

Olivier Audemard, MBA

Chief Financial Officer

Bob Dufour, MBA

Chief Business Officer

View full Traverse Biotech profile